Submitted by Anonymous (not verified) on 14 October 2025 - 15:16
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 4, Status: Authorised